AGIO

#1757
Agios Pharmaceuticals, Inc.
30.2300
+3.63%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
30.2300
30.2300
Jahresspanne
22.2400
45.9900
Tagesänderung
+3.63%
Monatliche Änderung
+5.00%
6 month change
-30.33%
Jahresänderung
-30.33%
Vorheriger Schlusskurs
29.1700
Open
30.2300
Bid
Ask
Low
30.2300
High
30.2300
Volumen
96
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.7525 B
  • Employee 540
  • Founded 2008
  • CEO N/A
  • Website www.agios.com
  • Headquarter Delaware, United States
  • FIGI BBG000QY4ZD0
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.82
Price to sales ratio
29.21
Dividends per share
—
Dividend yield %
—

Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Nachrichten